- Report
- April 2025
- 118 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 192 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 136 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2022
- 120 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- January 2024
- 147 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- November 2021
- 120 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2018
Australia
From €7276EUR$7,995USD£6,238GBP
- Report
- November 2018
South Korea
From €7276EUR$7,995USD£6,238GBP
- Report
- November 2018
China
From €7276EUR$7,995USD£6,238GBP
- Report
- November 2018
Japan
From €7276EUR$7,995USD£6,238GBP
- Report
- August 2024
- 104 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Femoral Stem market is a segment of the Orthopedic Devices industry. Femoral Stems are medical implants used to replace the femur, or thigh bone, in hip replacement surgeries. Femoral Stems are typically made of titanium or cobalt chrome and are designed to fit into the femur and provide stability and support for the artificial hip joint. Femoral Stems are designed to last for many years, and are often used in combination with other orthopedic devices such as hip cups and acetabular components.
The Femoral Stem market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Zimmer Biomet, Stryker, Smith & Nephew, DePuy Synthes, and B. Braun. Show Less Read more
